2024-03-22 19:32:03
(ANSA) – PADUA, MARCH 22 – There is a need for a system “that integrates genetic information with that which comes from other data, such as clinical, environmental or previous diseases, in order to develop a coherent and complete profile of the person, to see what the risks and benefits are and how we can intervene in an optimal way”. This was stated by Alessandro Doria, professor of medicine at Harvard Medical School and senior researcher and head of the genetics and epidemiology section of the Joslin Diabetes Center in Boston.
His speech opened the third day of the World Health Forum Veneto today at the Sala Mantegna of Padova Congress.
“During the last 15 years we have seen a great development of knowledge regarding multifactorial diseases such as diabetes, obesity, asthma and hypertension – stated Doria, a Venetian, graduate from the University of Padua -. This information can be evaluated on the person, considering both the genetic and environmental risk. This can be used to decide whether and which prevention therapies to implement”.
There is now a lot of so-called Big Data and it is therefore necessary to be able to analyze it in a suitable and fast way, “and this is only possible thanks to the use of artificial intelligence. Also because it is absolutely not feasible for a doctor to analyze millions and millions of genetic variants “.
Doria then wanted to make a comparison between the Italian healthcare system and the US one, and on the applications of AI already in progress: “Italy is not behind in research – explained Doria -. However, it should be underlined that in the US much more is being done in this field. But the practical implementation of this new program with AI and genetics has not yet been achieved.” (HANDLE).
2024-03-22 19:32:03